Anti-HLA-G antibodies, compositions comprising anti-HLA-G antibodies and methods of using anti-HLA-G antibodies

US11208487B2 · kind B2 · utility

Assignee

• Tizona Therapeutics · US

Inventors

• Courtney Beers · Seattle, US
• John Corbin · Oakland, US
• Doug Hodges · South San Francisco, US
• Achim Moesta · South San Francisco, US
• Vanessa Soros · South San Francisco, US
• Paul Fredrick Widboom · Lebanon, US
• Joseph Robert Warfield · South San Francisco, US

Key dates

• Filing date: Sep 26, 2019
• Grant date: Dec 28, 2021
• Expiry date: Jan 20, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are antibodies that selectively bind to HLA-G and compositions comprising the antibodies. Also provided are methods of using the antibodies, such as therapeutic and diagnostic methods.